POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature
Autor: | Chakra Diwaker, Tushar Bandgar, Swati Jadhav, Anurag R. Lila, Virendra Patil, Jugal V Gada, Shantanu Kale, Puja M Thadani, Vijaya Sarathi, Nalini S. Shah, Sneha Arya |
---|---|
Rok vydání: | 2021 |
Předmět: |
Pediatrics
medicine.medical_specialty business.industry Endocrinology Diabetes and Metabolism Nonsense mutation 030209 endocrinology & metabolism Retrospective cohort study Compound heterozygosity medicine.disease Pubarche 03 medical and health sciences 0302 clinical medicine Endocrinology Cohort Genotype Medicine Missense mutation Precocious puberty business 030217 neurology & neurosurgery |
Zdroj: | Pituitary. 24:657-669 |
ISSN: | 1573-7403 1386-341X |
DOI: | 10.1007/s11102-021-01140-9 |
Popis: | POU1F1 mutations are prevalent in Indian CPHD cohorts. Genotype–phenotype correlation is not well-studied. To describe phenotypic and genotypic spectrum of POU1F1 mutations in our CPHD cohort and present systematic review as well as genotype–phenotype analysis of all mutation-positive cases reported in world literature. Retrospective study of POU1F1 mutation-positive patients from a western-Indian center. PRISMA guidelines based pubmed search of published literature of all mutation-positive patients. Our cohort had 15 POU1F1 mutation-positive patients (9 index, 6 relatives). All had severe GH, TSH and prolactin deficiencies (GHD, TSHD and PD). TSHD was diagnosed earliest followed by GHD (median ages: TSHD-6 months, GHD-3 years), while PD was more variable. Two sisters had central precocious puberty at 7 years of age. Pubic hair was deficient in all post-pubertal patients (females: P1-P2, males: P3-P4). Splice-site/intronic/frameshift mutations were most common, while missense/nonsense mutations were less frequent (33%). Review of world literature yielded 114 patients (82 index patients) from 58 studies. GHD was present in all patients. TSHD was spared in 12.5% and PD in 4.4% patients. Missense/nonsense mutations accounted for 75% of spectrum. Phenotype-genotype analysis revealed higher mean peak-GH levels (1.1 vs 0.2 ng/ml, p = 0.008) and lower prevalence of anterior-pituitary hypoplasia (63.6% vs 86.3%, p = 0.03) in patients with heterozygous than homozygous and compound heterozygous mutations. We present largest series of POU1F1 mutation-positive patients. Precocious puberty and defective pubarche are lesser-appreciated phenotypic features. Our mutation spectrum is different from that of world literature. Patients with heterozygous mutations have milder phenotype. |
Databáze: | OpenAIRE |
Externí odkaz: |